Qureight
Qureight is a clinical data analytics company that harnesses AI to accelerate drug development, focusing on lung and heart diseases.
Company facts
- Founded
- 2018
- Headquarters
- United Kingdom
- CEO
- Dr. Muhunthan Thillai
About
Qureight is a pioneering Core Imaging Laboratory that specializes in accelerating drug development through AI-powered data curation. Founded in Cambridge, United Kingdom, we collaborate with biopharma, contract research organizations, and healthcare institutions to enhance the efficacy of clinical trials, especially in lung and heart disease therapies. With a dedicated focus on improving clinical trial outcomes, Qureight employs advanced machine learning algorithms and cloud-based technology to curate and analyze complex healthcare data. Our platform enables real-time access to structured clinical trial data and integrates imaging, clinical data, and biomarkers to facilitate better decision-making in drug development. Our mission is clear: transform the conventional approaches to clinical trials by leveraging innovative AI solutions to uncover insights that can expedite the approval process for life-saving therapies. We are committed to redefining precision medicine, ensuring that healthcare innovations translate into improved patient outcomes, and ultimately, changing lives. Qureight's journey is built on integrity, collaboration, and a relentless drive to push the boundaries of science and technology in healthcare.